Gyre Therapeutics (GYRE) Gross Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21,616.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -5,872.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,872.00 |
| Dec 31, 2025 | -16,114.00 |
| Sep 30, 2025 | -157.00 |
| Jun 30, 2025 | -125.00 |
| Mar 31, 2025 | -45.00 |
| Dec 31, 2024 | 38.00 |
| Sep 30, 2024 | -6.00 |
| Jun 30, 2024 | 62.00 |
| Mar 31, 2024 | 91.00 |
| Dec 31, 2023 | 4,805.00 |
| Mar 31, 2023 | 9,599.00 |
| Dec 31, 2022 | 4,792.00 |
| Mar 31, 2022 | 38.00 |
| Dec 31, 2021 | 4,512.00 |
| Sep 30, 2021 | -192.00 |
| Jun 30, 2021 | -9,923.00 |
| Mar 31, 2021 | -9,214.00 |